Why the IMNN-001 and PARP inhibitor pairing could matter more than the standalone data in ovarian cancer
FDA engagement signals cautious progress for AEON Biopharma Inc. in complex biologics space (NYSE American: AEON)
Read More 2 minute read Technology Industry News Tech Mahindra launches VerifAI: A game-changer in validating and verifying AI projects globally In a move set to transform how enterprises handle artificial intelligence (AI), Tech Mahindra has unveiled TechM VerifAI,… byPallavi MadhirajuJuly 31, 2024